Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Merus gets FDA approval of BIZENGRI
FDA approves AstraZeneca's Imfinzi for limited-stage small cell lung cancer
The U.S. Food and Drug Administration has approved AstraZeneca blockbuster drug Imfinzi to treat some adults with limited-stage small cell lung cancer, the health regulator said on Wednesday.
FDA signs off on Merus' first-in-class NRG1+ cancer drug Bizengri after brief delay
Merus’ week keeps getting better. Days after securing a long-awaited commercialization partner for its zenocutuzumab, the drug has crossed the FDA finish line as the first therapy to target cancers that harbor a neuregulin 1 (NRG1) gene fusion.
FDA Grants Accelerated Approval For Merus' BIZENGRI For Pancreatic Adenocarcinoma And NSCLC
Merus N.V. (MRUS) announced that the U.S. Food and Drug Administration has granted accelerated approval for BIZENGRI
US FDA approves Merus' therapy to treat lung, pancreatic cancers
The U.S. Food and Drug Administration has approved Merus NV's therapy that targets a particular gene, offering a treatment option for patients with hard-to-treat type of lung and pancreatic cancers, the health regulator said on Wednesday.
Merus Gets FDA Approval for Bizengri Treatment
The clinical-stage oncology company on Wednesday said Bizengri is its first approved medicine based on the proprietary Biclonics technology platform. The approval is based on data from the eNRGy trial,
Merus gets FDA approval for Bizengri for NRG1+ cancers
Merus (NASDAQ:MRUS) has received accelerated FDA approval for its drug Bizengri for the treatment of NRG1+ cancers of the pancreas and lung. The agency approved Bizengri, also known as zenocutuzumab-zbco,
14h
on MSN
Supplement Recall Update: FDA Adds Two More Toxic Products to Safety Alert
A safety alert by the FDA now covers 25 products sold as tejocote but found to contain a toxic plant called yellow oleander.
Psychology Today
6h
FDA Under Trump and the Future of Psychedelics
With Trump back in the White House, will FDA policies on psychedelics shift? What's the impact on mental health care and ...
16h
on MSN
How the FDA allows companies to add secret ingredients to our food
The FDA allows food makers to vouch for the safety of ingredients they add to our food, calling them 'generally recognized as ...
STAT
13h
Compounding pharmacies rebut Novo’s FDA petition
The Alliance for Pharmacy Compounding rebutted Novo's FDA petition to bar compounding pharmacies from copying its weight loss ...
11h
on MSN
Sauce Recall Update as FDA Sets Risk Level
Anyone who thinks they may have suffered a reaction due to undeclared allergens should also "notify the FDA and local health ...
14h
RFK Jr. Says He Wants To Untie Links Between Industry And FDA
It's unclear to what extent RFK Jr would want to disrupt a drug review process that has given the US a comparative advantage, ...
medtechdive
11h
FDA issues final guidance on postmarket updates to AI-enabled devices
By using pre-determined change control plans, manufacturers can update AI-enabled devices without filing an additional FDA ...
soapcentral
15h
FDA announces carrots, broccoli, and more vegetables recall due to possible E.coli contamination: Drama explained
In the latest twist, the FDA has recalled multiple brands of Organic Vegetable Medley sold at grocery stores like Walmart, ...
1d
SCOTUS appears to lean toward FDA in e-cig case
FDA’S DAY AT SCOTUS — Don’t expect the Supreme Court to take a sledgehammer to the FDA’s ability to regulate tobacco.
9h
on MSN
FDA tags Wegovy with new warning for gastrointestinal reactions
Participants in Wegovy clinical trials were more likely to report “severe gastrointestinal adverse reactions,” the FDA's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Donald Trump
Food and Drug Administration
Supreme Court of the United States
cucumber recall
CDC
Feedback